Previous article Next article

The EU Court of First Instance states that a Commission’s letter does not produce a legally binding effect and therefore cannot be challenged by drug companies (Nefarma)

Case T-113/89 Nederlandse Associatie van de Farmaceutische Industrie 'Nefarma' and Bond van Groothandelaren in het Farmaceutische Bedrijf v Commission of the European Communities* A letter addressed to the authorities of a Member State by a Member of the Commission which merely represents an initial evaluation, by

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.